Correlation Between Visa and Maccura Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Maccura Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Maccura Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Maccura Biotechnology Co, you can compare the effects of market volatilities on Visa and Maccura Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Maccura Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Maccura Biotechnology.

Diversification Opportunities for Visa and Maccura Biotechnology

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Visa and Maccura is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Maccura Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maccura Biotechnology and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Maccura Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maccura Biotechnology has no effect on the direction of Visa i.e., Visa and Maccura Biotechnology go up and down completely randomly.

Pair Corralation between Visa and Maccura Biotechnology

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.6 times more return on investment than Maccura Biotechnology. However, Visa Class A is 1.67 times less risky than Maccura Biotechnology. It trades about 0.33 of its potential returns per unit of risk. Maccura Biotechnology Co is currently generating about -0.01 per unit of risk. If you would invest  28,268  in Visa Class A on August 25, 2024 and sell it today you would earn a total of  2,724  from holding Visa Class A or generate 9.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Visa Class A  vs.  Maccura Biotechnology Co

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Maccura Biotechnology 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Maccura Biotechnology Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maccura Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Visa and Maccura Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Maccura Biotechnology

The main advantage of trading using opposite Visa and Maccura Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Maccura Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maccura Biotechnology will offset losses from the drop in Maccura Biotechnology's long position.
The idea behind Visa Class A and Maccura Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum